Burcon Nutrascience Corporation (BU) Q4 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Music Music Music Music Music . . . . . . . . . . Thank you. Thank you. Thank you. Good afternoon, everyone, and thank you for participating in today's conference call to discuss Berken Nutrascience Corporation's fiscal 2026 results, year ended March 31st, 2026. Joining us today are Keith Underwood, Berken's chief executive officer, and Alex Barty, the company's interim chief financial officer. Following their presentation, we will open up the call for your questions. After the presentation, there will be an opportunity to ask questions. To join the question queue, you may press a star, then one on your telephone keypad. Should you need assistance during the conference call, you may signal an operator by pressing star, then zero. Then before we conclude today's call, I'll provide the company's safe harbor statement with the important questions regarding the forward-looking statements made during this call. Now, I would like to turn the call over to the CEO of Birkin, Mr. Keith Underwood. Sir, please go ahead. Thank you, operator, and good morning, good afternoon, and good evening to those attending the call today. We very much appreciate you taking time out of your day to spend time with us. We want you all to have three takeaways from today's presentation. The first is that we are targeting a large growing market. The second, that our technology platform delivers highly differentiated products. And I think three, maybe most importantly, is throughout fiscal 26, we are delivering on commercial success. our standard safe harbor statement. Before we get into fiscal 26, I want to take a step back and kind of go through a couple of key points as to why we are so excited about the opportunity in front of us. The first is I think many of you can probably see protein is eve...